Education
About Us
Working with TipRanks
Follow Us
Surgical Science Sweden AB (SE:SUS)
:SUS
Total Valuation
Surgical Science Sweden AB has a market cap or net worth of kr1.73B. The enterprise value is kr3.89B.
Market Capkr1.73B
Enterprise Valuekr3.89B
Share Statistics
Surgical Science Sweden AB has 51,026,237 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,026,237
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Surgical Science Sweden AB’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.41%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)2.41%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee3.23M
Profits Per Employee480.46K
Employee Count274
Asset Turnover0.16
Inventory Turnover1.59
Valuation Ratios
The current PE Ratio of Surgical Science Sweden AB is 24.8. Surgical Science Sweden AB’s PEG ratio is -1.38.
PE Ratio24.8
PS Ratio9.00
PB Ratio1.65
Price to Fair Value1.65
Price to FCF88.69
Price to Operating Cash Flow17.42
PEG Ratio-1.38
Income Statement
In the last 12 months, Surgical Science Sweden AB had revenue of 884.09M and earned 131.65M in profits. Earnings per share was 2.58.
Revenue884.09M
Gross Profit597.90M
Operating Income144.32M
Pretax Income158.09M
Net Income131.65M
EBITDA224.29M
Earnings Per Share (EPS)2.58
Cash Flow
In the last 12 months, operating cash flow was 63.56M and capital expenditures -46.34M, giving a free cash flow of 17.22M billion.
Operating Cash Flow63.56M
Free Cash Flow17.22M
Free Cash Flow per Share0.34
Dividends & Yields
Surgical Science Sweden AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change-78.28%
50-Day Moving Average69.76
200-Day Moving Average114.06
Relative Strength Index (RSI)23.39
Average Volume (3m)1.54M
Important Dates
Surgical Science Sweden AB upcoming earnings date is Feb 19, 2026, TBA (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend Date―
Financial Position
Surgical Science Sweden AB as a current ratio of 2.78, with Debt / Equity ratio of 0.04%
Current Ratio2.78
Quick Ratio2.43
Debt to Market Cap0.03
Net Debt to EBITDA-3.01
Interest Coverage Ratio25.41
Taxes
In the past 12 months, Surgical Science Sweden AB has paid 26.45M in taxes.
Income Tax26.45M
Effective Tax Rate0.17
Enterprise Valuation
Surgical Science Sweden AB EV to EBITDA ratio is 32.45, with an EV/FCF ratio of 81.15.
EV to Sales8.23
EV to EBITDA32.45
EV to Free Cash Flow81.15
EV to Operating Cash Flow53.05
Balance Sheet
Surgical Science Sweden AB has kr597.39M in cash and marketable securities with kr1.63M in debt, giving a net cash position of kr595.76M billion.
Cash & Marketable Securitieskr597.39M
Total Debtkr1.63M
Net Cashkr595.76M
Net Cash Per Sharekr11.68
Tangible Book Value Per Sharekr17.66
Margins
Gross margin is 67.86%, with operating margin of 16.32%, and net profit margin of 14.89%.
Gross Margin67.86%
Operating Margin16.32%
Pretax Margin17.88%
Net Profit Margin14.89%
EBITDA Margin25.37%
EBIT Margin18.52%
Analyst Forecast
The average price target for Surgical Science Sweden AB is kr40.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Targetkr40.00
Price Target Upside-52.66% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast13.40%
EPS Growth Forecast-63.89%